Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R



TSX:CXR.R - Post by User

Post by Whiskeytimeon Feb 09, 2017 10:26am
492 Views
Post# 25822330

(CXRX) Receives $35.76 Average Price Target from Analysts

(CXRX) Receives $35.76 Average Price Target from Analysts




Concordia International Corp. (CXRX) Receives $35.76 Average Price Target from Analysts

Shares of Concordia International Corp. (NASDAQ:CXRX) (TSE:CXR) have been given a consensus recommendation of “Hold” by the thirteen brokerages that are covering the stock. Five analysts have rated the stock with a sell rating, four have given a hold rating and three have assigned a buy rating to the company. The average 1 year price objective among brokers that have issued ratings on the stock in the last year is $35.76.

A number of research analysts have commented on CXRX shares. Canaccord Genuity set a $10.00 price objective on Concordia International Corp. and gave the stock a “buy” rating in a research note on Monday, October 24th. Zacks Investment Research upgraded Concordia International Corp. from a “strong sell” rating to a “hold” rating in a research note on Monday, October 17th. Bloom Burton reiterated a “hold” rating on shares of Concordia International Corp. in a research note on Wednesday, October 26th. RBC Capital Markets reiterated an “outperform” rating and issued a $13.50 price target (down previously from $18.75) on shares of Concordia International Corp. in a research note on Sunday, November 6th. Finally, Scotiabank reiterated a “sector perform” rating and issued a $4.50 price target (down previously from $8.00) on shares of Concordia International Corp. in a research note on Wednesday, October 12th.

Concordia International Corp. (NASDAQ:CXRX) opened at 2.05 on Monday. The company’s 50-day moving average price is $2.17 and its 200-day moving average price is $6.70. Concordia International Corp. has a 1-year low of $1.69 and a 1-year high of $35.23. The stock’s market cap is $104.58 million.

 

Concordia International Corp. (NASDAQ:CXRX) last issued its quarterly earnings data on Monday, November 7th. The company reported $0.69 EPS for the quarter, missing the Zacks’ consensus estimate of $1.05 by $0.36. The company had revenue of $185.50 million for the quarter, compared to analyst estimates of $206 million. Concordia International Corp. had a positive return on equity of 22.81% and a negative net margin of 81.40%. The company’s revenue for the quarter was up 99.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.46 EPS. Analysts predict that Concordia International Corp. will post $4.05 EPS for the current year.

A number of hedge funds have recently made changes to their positions in the stock. Point72 Asset Management L.P. raised its stake in shares of Concordia International Corp. by 1,738.9% in the second quarter. Point72 Asset Management L.P. now owns 1,197,100 shares of the company’s stock valued at $25,786,000 after buying an additional 1,132,000 shares in the last quarter. Nomura Holdings Inc. raised its position in Concordia International Corp. by 1,183.4% in the second quarter. Nomura Holdings Inc. now owns 552,150 shares of the company’s stock valued at $11,939,000 after buying an additional 509,127 shares during the period. Wingspan Investment Management LP bought a new position in Concordia International Corp. during the second quarter valued at approximately $8,374,000. The Manufacturers Life Insurance Company bought a new position in Concordia International Corp. during the third quarter valued at approximately $1,012,000. Finally, Morgan Stanley raised its position in Concordia International Corp. by 11,075.4% in the third quarter. Morgan Stanley now owns 157,126 shares of the company’s stock valued at $704,000 after buying an additional 155,720 shares during the period. 36.80% of the stock is owned by hedge funds and other institutional investors.


<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse